Innovative Product Focus ResQ Pharma specializes in lipid-based therapies targeting critical, life-threatening conditions, positioning the company as a crucial partner for healthcare providers and hospitals that require reliable emergency treatment solutions.

Near Market Launch With a PDUFA date set for June 2025, the company's flagship product is imminent for market entry, presenting an opportunity to establish early relationships with key healthcare institutions and regulatory bodies.

Growing Revenue Potential Projected revenue between one to ten million dollars reflects significant market demand for critical care pharmaceuticals, indicating strong sales prospects in emergency medicine and hospital settings.

Technology-Enabled Reach Utilizing advanced tech infrastructure such as AWS and PWA, ResQ Pharma demonstrates modern, scalable digital engagement capabilities, which can be leveraged to facilitate product education, ordering, and customer support.

Smaller, Focused Team With a compact team of up to 10 employees, ResQ Pharma offers flexible partnership opportunities with personalized service, making it attractive for healthcare distributors and partners seeking dedicated collaboration.